Clinical Trial Update: Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intratumoral injection of H101, an oncolytic virus, with or without radiotherapy for refractory or recurrent gynecologic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• H101 (oncolytic adenovirus H101)

Snippet

Sponsor: Liu Zi | Conditions: Genital Neoplasms, Female | Phase 2 | Status: ACTIVE_NOT_RECRUITING